Literature DB >> 27583657

Does Hypoxis hemerocallidea mitigate renal histopathological injuries following highly active antiretroviral therapy? An experimental animal study.

Ugochukwu Offor1, Ayoola I Jegede1,2, Ismail O Onanuga1,3, Edwin C Naidu1, Onyemaechi O Azu4.   

Abstract

BACKGROUND: Nephrotoxicity has become an important public health problem following the success recorded with highly active antiretroviral therapy, and there is paucity of literature reporting the attenuating influence of plant-based adjuvants that can mitigate the effects.
METHODS: Sixty three adult male Sprague-Dawley rats were divided into 9 groups (A-I) and treated as follows: group A received HAART cocktail (lamivudine, stavudine and nevirapine), group B received HAART and Hypoxis hemerocallidea (HH) extract (200 mg/kg), group C received HAART and HH (100 mg/kg), group D received HAART and vitamin C, group E received HAART and vitamin E, group F received HAART, vitamin C and vitamin E, group G received HH extract (100 mg/kg), group H received HH extract (200 mg/kg), and group I received saline as placebo. After 56 days, animals were euthanized, kidneys harvested and prepared for H&E staining and blood samples were collected for BUN and serum creatinine analyses.
RESULTS: The results from histological slides showed distorted glomerular and epithelial components with extensive loss of Bowman's capillary integrity in HAART-treated group. Adjuvant treatment with HH both high and low doses did not show any remarkable attenuating influence. However, HH100mg/kg-alone treated group showed improved histological layout as compared to the higher dose. Co-administration of HAART and vitamins C and E did not improve the parameters examined. The serum creatinine and BUN levels were significantly increased (P<0.05) following HAART with observable increase in kidney body weight ratio. SCR levels in group D was significantly reduced (P<0.05) but elevated in groups B, C, G and H (P<0.001). Groups B and C, as well as groups F and H recorded higher BUN values (P<0.05).
CONCLUSIONS: Adjuvant treatment with HH extract did not attenuate the nephrotoxicity of HAART in this model.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27583657     DOI: 10.23736/S0393-2249.16.02651-5

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  2 in total

1.  Momordica charantia mitigates hepatic injury following adjuvant treatment with antiretroviral drugs in diabetic animal models.

Authors:  Ugochukwu Offor; Edwin C S Naidu; Oluwatosin O Ogedengbe; Peter I Aniekan; Onyemaechi O Azu
Journal:  Toxicol Res       Date:  2019-12-02

2.  Renal histopathological and biochemical changes following adjuvant intervention of Momordica charantia and antiretroviral therapy in diabetic rats.

Authors:  Ugochukwu Offor; Coleridge Stephen Naidu Edwin; Oluwatosin Olalekan Ogedengbe; Ayoola Isaac Jegede; Aniekan Imo Peter; Okpara Azu Onyemaechi
Journal:  Iran J Basic Med Sci       Date:  2019-11       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.